These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 34751429)

  • 21. Primary adrenal insufficiency associated with Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia (VITT).
    Varona JF; García-Isidro M; Moeinvaziri M; Ramos-López M; Fernández-Domínguez M
    Eur J Intern Med; 2021 Sep; 91():90-92. PubMed ID: 34256983
    [No Abstract]   [Full Text] [Related]  

  • 22. Cutaneous Lymphocytic Vasculitis After Administration of the Second Dose of AZD1222 (Oxford-AstraZeneca) Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination: Casuality or Causality?
    Ungari M; Pezzarossa E
    Am J Dermatopathol; 2022 Jan; 44(1):80-82. PubMed ID: 34726187
    [No Abstract]   [Full Text] [Related]  

  • 23. AZD1222 vaccine-related coagulopathy and thrombocytopenia without thrombosis in a young female.
    Ryan E; Benjamin D; McDonald I; Barrett A; McHugh J; Ryan K; Enright H
    Br J Haematol; 2021 Aug; 194(3):553-556. PubMed ID: 34036570
    [No Abstract]   [Full Text] [Related]  

  • 24. Anti-SARS-CoV-2 Spike Protein RBD Antibody Levels After Receiving a Second Dose of ChAdOx1 nCov-19 (AZD1222) Vaccine in Healthcare Workers: Lack of Association With Age, Sex, Obesity, and Adverse Reactions.
    Lee SW; Moon JY; Lee SK; Lee H; Moon S; Chung SJ; Yeo Y; Park TS; Park DW; Kim TH; Sohn JW; Yoon HJ; Kim SH
    Front Immunol; 2021; 12():779212. PubMed ID: 34899739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of Thromboembolic and Thrombocytopenic Events After the AZD1222, BNT162b2, and MRNA-1273 COVID-19 Vaccines in 3 Nordic Countries.
    Dag Berild J; Bergstad Larsen V; Myrup Thiesson E; Lehtonen T; Grøsland M; Helgeland J; Wolhlfahrt J; Vinsløv Hansen J; Palmu AA; Hviid A
    JAMA Netw Open; 2022 Jun; 5(6):e2217375. PubMed ID: 35699955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Prendiville J
    Adv Dermatol; 2002; 18():151-73. PubMed ID: 12528405
    [No Abstract]   [Full Text] [Related]  

  • 27. Fertility rates and birth outcomes after ChAdOx1 nCoV-19 (AZD1222) vaccination.
    Hillson K; Clemens SC; Madhi SA; Voysey M; Pollard AJ; Minassian AM;
    Lancet; 2021 Nov; 398(10312):1683-1684. PubMed ID: 34688353
    [No Abstract]   [Full Text] [Related]  

  • 28. Aseptic meningitis following AZD1222 COVID-19 vaccination.
    Zavari A; Hamidabad NM; Hassanzadeh M
    Am J Emerg Med; 2022 May; 55():225.e5-225.e6. PubMed ID: 34955313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphomatoid papulosis (LyP) after AZD1222 and BNT162b2 COVID-19 vaccines.
    Koumaki D; Marinos L; Nikolaou V; Papadakis M; Zografaki K; Lagoudaki E; Kotopouli FE; Krasagakis K; Krueger-Krasagakis SE
    Int J Dermatol; 2022 Jul; 61(7):900-902. PubMed ID: 35584258
    [No Abstract]   [Full Text] [Related]  

  • 30. Postvaccinal GABA-B receptor antibody encephalitis after ChAdOx1 nCoV-19 vaccination.
    Ahn SJ; Lee ST; Chu K
    Ann Clin Transl Neurol; 2022 Oct; 9(10):1673-1678. PubMed ID: 36053935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenicity and safety of AZD1222 (ChAdOx1 nCoV-19) against SARS-CoV-2 in Japan: a double-blind, randomized controlled phase 1/2 trial.
    Asano M; Okada H; Itoh Y; Hirata H; Ishikawa K; Yoshida E; Matsui A; Kelly EJ; Shoemaker K; Olsson U; Vekemans J
    Int J Infect Dis; 2022 Jan; 114():165-174. PubMed ID: 34688944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuralgic Amyotrophy After ChAdOx1 nCoV-19 COVID-19 Vaccination.
    James J; Johnson J; Jose J
    J Clin Neuromuscul Dis; 2022 Dec; 24(2):112-113. PubMed ID: 36409345
    [No Abstract]   [Full Text] [Related]  

  • 33. Stevens-Johnson syndrome/toxic epidermal necrolysis overlap in a NSCLC patient treated with afatinib.
    Nühnen VP; Schön MP; Mössner R
    J Dtsch Dermatol Ges; 2018 Feb; 16(2):199-201. PubMed ID: 29328518
    [No Abstract]   [Full Text] [Related]  

  • 34. Postvaccinal Encephalitis after ChAdOx1 nCov-19.
    Zuhorn F; Graf T; Klingebiel R; Schäbitz WR; Rogalewski A
    Ann Neurol; 2021 Sep; 90(3):506-511. PubMed ID: 34324214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coincidental Onset of Ocular Myasthenia Gravis Following ChAdOx1 n-CoV-19 Vaccine against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Galassi G; Rispoli V; Iori E; Ariatti A; Marchioni A
    Isr Med Assoc J; 2022 Jan; 24(1):9-10. PubMed ID: 35077038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extensive cutaneous lichen planus triggered by viral vector COVID-19 vaccination (ChAdOx1 nCoV-19).
    Masseran C; Calugareanu A; Caux F; Bohelay G
    J Eur Acad Dermatol Venereol; 2022 Apr; 36(4):e263-e265. PubMed ID: 34936145
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunogenicity and reactogenicity after heterologous prime-boost vaccination with CoronaVac and ChAdox1 nCov-19 (AZD1222) vaccines.
    Cohen G; Jungsomsri P; Sangwongwanich J; Tawinprai K; Siripongboonsitti T; Porntharukchareon T; Wittayasak K; Thonwirak N; Soonklang K; Sornsamdang G; Auewarakul C; Mahanonda N
    Hum Vaccin Immunother; 2022 Nov; 18(5):2052525. PubMed ID: 35323079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID-19-induced toxic epidermal necrolysis.
    Narang I; Panthagani AP; Lewis M; Chohan B; Ferguson A; Nambi R
    Clin Exp Dermatol; 2021 Jul; 46(5):927-929. PubMed ID: 33511662
    [No Abstract]   [Full Text] [Related]  

  • 39. Central nervous system adverse events after ChAdOx1 vaccination.
    Maramattom BV; Lotlikar RS; Sukumaran S
    Neurol Sci; 2022 Jun; 43(6):3503-3507. PubMed ID: 35275317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenotypic spectrum of serious cutaneous-only adverse event following immunization with COVID-19 vaccines: a multicentre case series and literature review.
    Balogun M; Millette D; Yip V; Chan SA; Lee P; Gamal N; Hashim N; Phillips D; Walsh M; Trehan P; Hanna-Bashara L; Abdullah A; Wernham A; Tso S
    Clin Exp Dermatol; 2022 Mar; 47(3):614-616. PubMed ID: 34748655
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.